ATE80032T1 - Therapeutische zusammensetzung fuer lebergehirnkomplikationen. - Google Patents
Therapeutische zusammensetzung fuer lebergehirnkomplikationen.Info
- Publication number
- ATE80032T1 ATE80032T1 AT89110959T AT89110959T ATE80032T1 AT E80032 T1 ATE80032 T1 AT E80032T1 AT 89110959 T AT89110959 T AT 89110959T AT 89110959 T AT89110959 T AT 89110959T AT E80032 T1 ATE80032 T1 AT E80032T1
- Authority
- AT
- Austria
- Prior art keywords
- valiolamine
- hyperammonemia
- compound
- formula
- treatment
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title 1
- -1 valiolamine compound Chemical class 0.000 abstract 5
- 206010020575 Hyperammonaemia Diseases 0.000 abstract 3
- VDLOJRUTNRJDJO-UHFFFAOYSA-N Valiolamine Natural products NC1CC(O)(CO)C(O)C(O)C1O VDLOJRUTNRJDJO-UHFFFAOYSA-N 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 3
- 125000002015 acyclic group Chemical group 0.000 abstract 1
- 125000000837 carbohydrate group Chemical group 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000002541 furyl group Chemical group 0.000 abstract 1
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP15384588 | 1988-06-22 | ||
| EP89110959A EP0350650B1 (de) | 1988-06-22 | 1989-06-16 | Therapeutische Zusammensetzung für Leber-Gehirnkomplikationen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE80032T1 true ATE80032T1 (de) | 1992-09-15 |
Family
ID=15571358
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT89110959T ATE80032T1 (de) | 1988-06-22 | 1989-06-16 | Therapeutische zusammensetzung fuer lebergehirnkomplikationen. |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US4996236A (de) |
| EP (1) | EP0350650B1 (de) |
| AT (1) | ATE80032T1 (de) |
| CA (1) | CA1336072C (de) |
| DE (1) | DE68902706T2 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6346382B1 (en) * | 1999-06-01 | 2002-02-12 | Vanderbilt University | Human carbamyl phosphate synthetase I polymorphism and diagnostic methods related thereto |
| US9486429B2 (en) * | 1999-06-01 | 2016-11-08 | Vanderbilt University | Therapeutic methods employing nitric oxide precursors |
| US7256202B2 (en) * | 2003-12-31 | 2007-08-14 | Halow George M | Composition and method for treatment of hepatic encephalopathy |
| JP5623916B2 (ja) * | 2008-01-31 | 2014-11-12 | バンダービルト・ユニバーシティＶａｎｄｅｒｂｉｌｔ Ｕｎｉｖｅｒｓｉｔｙ | 動脈瘤性くも膜下出血及び血管痙攣に対する医薬組成物 |
| CA2714272C (en) * | 2008-01-31 | 2016-06-28 | Vanderbilt University | Therapeutic treatment for lung conditions |
| US9616075B2 (en) | 2012-07-20 | 2017-04-11 | University Of Rochester | Method of treating and preventing brain impairment using Na+-K+-2Cl-cotransporter isoform 1 inhibitors |
| CN108003042B (zh) * | 2017-12-29 | 2020-08-14 | 山东新华制药股份有限公司 | 伏格列波糖杂质n‐甲基井岗酶醇胺的制备工艺 |
| CN108059603B (zh) * | 2017-12-29 | 2020-08-14 | 山东新华制药股份有限公司 | 伏格列波糖杂质n-甲基井岗酶醇胺的精制工艺 |
-
1989
- 1989-05-15 US US07/351,462 patent/US4996236A/en not_active Expired - Fee Related
- 1989-05-29 CA CA000600944A patent/CA1336072C/en not_active Expired - Fee Related
- 1989-06-16 DE DE8989110959T patent/DE68902706T2/de not_active Expired - Fee Related
- 1989-06-16 EP EP89110959A patent/EP0350650B1/de not_active Expired - Lifetime
- 1989-06-16 AT AT89110959T patent/ATE80032T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0350650A1 (de) | 1990-01-17 |
| CA1336072C (en) | 1995-06-27 |
| US4996236A (en) | 1991-02-26 |
| DE68902706D1 (de) | 1992-10-08 |
| DE68902706T2 (de) | 1993-02-25 |
| EP0350650B1 (de) | 1992-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR880006229A (ko) | 항궤양 활성을 갖는 피리딘 유도체 | |
| HUT38256A (en) | Process for producing combined pharmaceutical compositions containing xantine derivatives and o-acetyl-salicylic acid or pharmaceutically acceptables salts | |
| KR850000462A (ko) | [[비스(아릴)메틸렌]-1-피페리디닐]알킬-피리미딘온의 제조방법 | |
| IL99699A0 (en) | Method of treating or preventing type 1 diabetes by oral administration of insulin | |
| KR900006341A (ko) | 이형고리 화합물 | |
| KR890011592A (ko) | 기관내 허혈병의 치료용 조성물 | |
| DK0583421T3 (da) | Substituerede dibenzoxazepinforbindelser, lægemidler og fremgangsmåder til anvendelse | |
| NO915122L (no) | N-substituerte cykloalkyl- og polycykloalkyl- alfa-substituerte trp-phe- og fenetylamin-derivater | |
| RU95105973A (ru) | Способ снижения тяжести токсоплазмоза, фармацевтическая композиция, применение производных рифамицина для получения лекарственных препаратов для лечения токсоплазмоза | |
| AU4466789A (en) | Xanthine derivatives | |
| DE68902706D1 (de) | Therapeutische zusammensetzung fuer leber-gehirnkomplikationen. | |
| KR890014480A (ko) | 2-피리딜아세트산 유도체, 이의 제조방법 및 이를 함유하는 약제학적 조성물 | |
| US5330978B1 (en) | Phosphonic acid derivatives and use thereof | |
| TW353658B (en) | Substituted tetrahydroisoquinoline compounds, pharmaceutical compositions containing them, and processes for their preparation | |
| NO880811L (no) | Krystalliserte cefam-syreaddisjonssalter og fremgangsmaatetil deres fremstilling. | |
| KR890003378A (ko) | 혐기성균에 대해 항균작용을 갖는 나프티리딘 화합물 | |
| KR970701191A (ko) | 복소환 화합물 | |
| EP0446921A3 (en) | Optically active alkylene-dioxybenzene derivatives and their use in therapy | |
| OA08881A (fr) | Nouveaux tripeptides à structure polycyclique azotée, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. | |
| DK72591D0 (da) | Hidtil ukendt s-timolol-derivat samt fremgangsmaade til fremstilling deraf | |
| EP0301474A3 (en) | New cysteine derivatives having expectorant activity | |
| KR880013896A (ko) | 벤조푸로[3,2-c]퀴놀린 화합물 | |
| KR890003372A (ko) | 피리미도[2,1-b] 벤조티아졸 유도체로된 동맥경화 치료의약 | |
| KR880013963A (ko) | 글루코피라노즈 유도체 | |
| KR910020023A (ko) | 헤테로사이클릭-nmda길항제 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |